STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD.;BEIJING STAIDSON MEDICAL TECHNOLOGY CO., LTD.
发明人:
Jianping TAN,Bingzhang WANG
申请号：
US15568455
公开号：
US20180161436A1
申请日:
2016.04.18
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention discloses nerve growth factor composition and an injection powder comprising the following components: 10 μg/mL-100 μg/mL of a nerve growth factor； 10 mg/mL-80 mg/mL of disaccharide stabilizer； 0 mg/mL-30 mg/mL of an amino acid stabilizer； 0.01 mg/mL-1 mg/mL of surfactant, 10 mg/mL-50 mg/mL of a supporting agent； a pH buffer for maintaining the nerve growth factor composition at 6.0-7.4, and solvent being water. The nerve growth factor composition and the injection powder can avoid the potential risk resulting from the virus of other unknown components carried in albumin by using a disaccharide or a combination of a disaccharide and an amino acid instead of albumin as a stabilizer； not only have protective effect on mNGF, but also can ensure the stability of hNGF and rhNGF in the preparation, transportation and storage processes, and have better medication safety and quality control.
